317 related articles for article (PubMed ID: 32443727)
1. IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer.
Cai Q; Dozmorov M; Oh Y
Cells; 2020 May; 9(5):. PubMed ID: 32443727
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer.
Ingermann AR; Yang YF; Han J; Mikami A; Garza AE; Mohanraj L; Fan L; Idowu M; Ware JL; Kim HS; Lee DY; Oh Y
J Biol Chem; 2010 Sep; 285(39):30233-46. PubMed ID: 20353938
[TBL] [Abstract][Full Text] [Related]
3. Unraveling insulin-like growth factor binding protein-3 actions in human disease.
Jogie-Brahim S; Feldman D; Oh Y
Endocr Rev; 2009 Aug; 30(5):417-37. PubMed ID: 19477944
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.
Oh Y
Kidney Res Clin Pract; 2012 Mar; 31(1):26-37. PubMed ID: 26889406
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
Ricort JM; Binoux M
J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
[TBL] [Abstract][Full Text] [Related]
6. Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy.
Mohanraj L; Oh Y
Recent Pat Anticancer Drug Discov; 2011 May; 6(2):166-77. PubMed ID: 21247403
[TBL] [Abstract][Full Text] [Related]
7. IGF-independent regulation of breast cancer growth by IGF binding proteins.
Oh Y
Breast Cancer Res Treat; 1998 Feb; 47(3):283-93. PubMed ID: 9516082
[TBL] [Abstract][Full Text] [Related]
8. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Miyamoto S; Yano K; Sugimoto S; Ishii G; Hasebe T; Endoh Y; Kodama K; Goya M; Chiba T; Ochiai A
Cancer Res; 2004 Jan; 64(2):665-71. PubMed ID: 14744783
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism.
Rajah R; Valentinis B; Cohen P
J Biol Chem; 1997 May; 272(18):12181-8. PubMed ID: 9115291
[TBL] [Abstract][Full Text] [Related]
11. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms.
Mohan S; Baylink DJ
J Endocrinol; 2002 Oct; 175(1):19-31. PubMed ID: 12379487
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding-protein-3 (IGFBP-3).
Ranke MB
Best Pract Res Clin Endocrinol Metab; 2015 Oct; 29(5):701-11. PubMed ID: 26522455
[TBL] [Abstract][Full Text] [Related]
13. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
14. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.
Yan X; Forbes BE; McNeil KA; Baxter RC; Firth SM
J Biol Chem; 2004 Dec; 279(51):53232-40. PubMed ID: 15485880
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
[TBL] [Abstract][Full Text] [Related]
17. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily.
Kim HS; Nagalla SR; Oh Y; Wilson E; Roberts CT; Rosenfeld RG
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12981-6. PubMed ID: 9371786
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells.
Oh Y; Gucev Z; Ng L; Müller HL; Rosenfeld RG
Prog Growth Factor Res; 1995; 6(2-4):503-12. PubMed ID: 8817695
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
Lawrence JB; Conover CA; Haddad TC; Ingle JN; Reid JM; Ames MM; Suman VJ; Marks RS; Erlichman C; Hartmann LC
Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein-3 and breast cancer survival.
Yu H; Levesque MA; Khosravi MJ; Papanastasiou-Diamandi A; Clark GM; Diamandis EP
Int J Cancer; 1998 Dec; 79(6):624-8. PubMed ID: 9842972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
